The KU Leuven spinout is researching remedies for debilitating diseases of the nervous system such as multiple sclerosis.

Quartet, the creator of a collaborative healthcare platform, took its total funding to $87m with a series C round featuring existing backer GV.

Scholar Rock will use the proceeds from the Kraft Group-backed round to advance its lead spinal muscular atrophy drug candidate into clinical development.

Novartis Venture Fund co-led a $20.3m round for Oculis, which is developing a topical liquid that can be applied to diseases at the back of the eye.

Tencent-backed plastic surgery marketplace SoYoung has obtained $60m in a series D round led by private equity fund Apax Digital.

Aegea has now raised $96m in overall financing, after securing funds from investors including existing backers Medtronic and BioMed Ventures.

Novartis Venture Fund and Sanofi Ventures are among the four investors that co-led Expansion Therapeutics' $55.3m series A round.

Restorbio, an aging-related disease drug developer co-founded by PureTech Health, also counts Novartis as a shareholder.